South Texas Renal Care Group Revenue and Competitors
Estimated Revenue & Valuation
- South Texas Renal Care Group's estimated annual revenue is currently $18M per year.
- South Texas Renal Care Group's estimated revenue per employee is $243,000
Employee Data
- South Texas Renal Care Group has 74 Employees.
- South Texas Renal Care Group grew their employee count by 12% last year.
South Texas Renal Care Group's People
Name | Title | Email/Phone |
---|
South Texas Renal Care Group Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $6.9M | 32 | -9% | N/A | N/A |
#2 | $8.6M | 40 | -13% | N/A | N/A |
#3 | $10.4M | 48 | 17% | N/A | N/A |
#4 | $42.2M | 142 | 14% | N/A | N/A |
#5 | $10.6M | 49 | 26% | N/A | N/A |
#6 | $8M | 37 | 6% | N/A | N/A |
#7 | $4M | 21 | -5% | N/A | N/A |
#8 | $8.9M | 41 | -7% | N/A | N/A |
#9 | $10.8M | 50 | 0% | N/A | N/A |
#10 | $8M | 37 | -24% | N/A | N/A |
What Is South Texas Renal Care Group?
Your kidneys. Our Passion. South Texas Renal Care Group is a physician-owned group of dedicated kidney specialists offering compassionate, full-service care for people suffering from kidney disease, diabetes and high blood pressure. With nine locations throughout San Antonio and South Texas, they treat chronic kidney disease, high blood pressure, lupus nephritis, glomerular/vascular disorders, proteinuria, hematuria, kidney stones and other kidney-related ailments and conditions. Their highly-skilled team of board-certified physicians, nephrologists and medical professionals believes in a unique and tailored approach to every patient, listening closely to the patients’ concerns and creating individualized treatment plans for each.
keywords:N/AN/A
Total Funding
74
Number of Employees
$18M
Revenue (est)
12%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $22M | 74 | 48% | N/A |
#2 | N/A | 74 | 30% | N/A |
#3 | N/A | 74 | -6% | N/A |
#4 | N/A | 74 | -3% | N/A |
#5 | $10.1M | 75 | 12% | N/A |